These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35117294)

  • 1. Cognitive impairment is related to a reduced count of T-lymphocytes in older patients diagnosed with non-small cell lung cancer (NSCLC).
    Soria-Comes T; Palomar-Abril V; Martín Ureste M; García Sánchez J; Marco Buades JE; Fernández Llavador MJ; López Gabaldón A; González Jurado M; Maestu Maiques IC
    Transl Cancer Res; 2020 Nov; 9(11):6857-6866. PubMed ID: 35117294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Age on Inflammation-Based Scores among Patients Diagnosed with Stage III Non-Small Cell Lung Cancer.
    Palomar-Abril V; Soria-Comes T; Tarazona Campos S; Martín Ureste M; Giner Bosch V; Maestu Maiques IC
    Oncology; 2020; 98(8):528-533. PubMed ID: 32203963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased CD8+CD28+ T cells independently predict better early response to stereotactic ablative radiotherapy in patients with lung metastases from non-small cell lung cancer.
    Liu C; Hu Q; Hu K; Su H; Shi F; Kong L; Zhu H; Yu J
    J Transl Med; 2019 Apr; 17(1):120. PubMed ID: 30971280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression.
    Wang Y; Zhou N; Zhu R; Li X; Sun Z; Gao Y; Liu W; Meng C; Ge Y; Bai C; Li T; Liu H
    BMC Pulm Med; 2021 Sep; 21(1):282. PubMed ID: 34488711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low peripheral blood derived neutrophil-to-lymphocyte ratio (dNLR) is associated with increased tumor T-cell infiltration and favorable outcomes to first-line pembrolizumab in non-small cell lung cancer.
    Alessi JV; Ricciuti B; Alden SL; Bertram AA; Lin JJ; Sakhi M; Nishino M; Vaz VR; Lindsay J; Turner MM; Pfaff K; Sharma B; Felt KD; Rodig SJ; Gainor JF; Awad MM
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34824161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune modulations during chemoimmunotherapy & novel vaccine strategies--in metastatic melanoma and non small-cell lung cancer.
    Iversen TZ
    Dan Med J; 2013 Dec; 60(12):B4774. PubMed ID: 24355457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy.
    Liu C; Wu S; Meng X; Liu G; Chen D; Cong Y; Shen G; Sun B; Wang W; Wang Q; Gao H; Liu X
    Oncotarget; 2017 Jun; 8(26):43427-43438. PubMed ID: 28624781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete Blood Cell Count-Derived Inflammatory Biomarkers in Early-Stage Non-Small-Cell Lung Cancer.
    Shoji F; Kozuma Y; Toyokawa G; Yamazaki K; Takeo S
    Ann Thorac Cardiovasc Surg; 2020 Oct; 26(5):248-255. PubMed ID: 32074540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral PD1-positive CD4 T-Lymphocyte Count Can Predict Progression-free Survival in Patients With Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitor.
    Inomata M; Kado T; Okazawa S; Imanishi S; Taka C; Kambara K; Hirai T; Tanaka H; Tokui K; Hayashi K; Miwa T; Hayashi R; Matsui S; Tobe K
    Anticancer Res; 2019 Dec; 39(12):6887-6893. PubMed ID: 31810958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated immune aging was correlated with lupus-associated brain fog in reproductive-age systemic lupus erythematosus patients.
    Kalim H; Pratama MZ; Mahardini E; Winoto ES; Krisna PA; Handono K
    Int J Rheum Dis; 2020 May; 23(5):620-626. PubMed ID: 32107852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying predictive biomarkers of CIMAvaxEGF success in non-small cell lung cancer patients.
    Lorenzo-Luaces P; Sanchez L; Saavedra D; Crombet T; Van der Elst W; Alonso A; Molenberghs G; Lage A
    BMC Cancer; 2020 Aug; 20(1):772. PubMed ID: 32807114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of CD4(+) and CD8(+) T cells in tumor islets and stroma from patients with non-small cell lung cancer in association with COPD and smoking.
    Jackutė J; Žemaitis M; Pranys D; Šitkauskienė B; Miliauskas S; Bajoriūnas V; Sakalauskas R
    Medicina (Kaunas); 2015 Nov; 51(5):263-71. PubMed ID: 26674143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase-II randomized study of pre-operative IL-2 administration in operable NSCLC.
    Masotti A; Morandini G; Ortolani R; Fumagalli L
    Lung Cancer; 1998 Jun; 20(3):191-202. PubMed ID: 9733054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttreatment Immune Parameters Predict Cancer Control and Pneumonitis in Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy.
    Zheng Y; Shi A; Wang W; Yu H; Yu R; Li D; Xu B; Ma H; You J; Zhao D; Jiang L; Geng J; Zhu G
    Clin Lung Cancer; 2018 Jul; 19(4):e399-e404. PubMed ID: 29519614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of PD1 and BTLA on the CD8
    Bao Y; Mo JF; Wu JY; Cao CX
    Chin Med Sci J; 2019 Nov; 34(4):248-255. PubMed ID: 33906710
    [No Abstract]   [Full Text] [Related]  

  • 16. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.
    Karagöz B; Bilgi O; Gümüs M; Erikçi AA; Sayan O; Türken O; Kandemir EG; Oztürk A; Yaylaci M
    Med Oncol; 2010 Mar; 27(1):29-33. PubMed ID: 19148592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.
    Li H; Yu H; Lan S; Zhao D; Liu Y; Cheng Y
    Technol Cancer Res Treat; 2021; 20():15330338211039948. PubMed ID: 34851203
    [No Abstract]   [Full Text] [Related]  

  • 18. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic changes in PD-L1 expression and CD8
    Choe EA; Cha YJ; Kim JH; Pyo KH; Hong MH; Park SY; Shim HS; Jung I; Lee CY; Cho BC; Kim HR
    Lung Cancer; 2019 Oct; 136():30-36. PubMed ID: 31421259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between peripheral blood lymphocyte subsets and clinical outcomes in patients with lung cancer treated with immune checkpoint inhibitor.
    Li P; Qin P; Fu X; Zhang G; Yan X; Zhang M; Zhang X; Yang J; Wang H; Ma Z
    Ann Palliat Med; 2021 Mar; 10(3):3039-3049. PubMed ID: 33849094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.